Treatment Horizons

Treatment Horizons

Targeting Dual Points of Entry

LifeGuide Two Birds, One Stone Researchers make advances with agents that can target dual points of entry by Mariel Selbovitz, MPH Drug discovery and early to mid-stage drug...

Man Up Mondays

An independent interim review of the Strategic Timing of AntiRetroviral Treatment (START) study findings shows that initializing treatment early improves outcomes for individuals with...

Ending Disparities

As the United States Conference on AIDS (USCA 2015) will convene shortly (September 10–13) in Washington, D.C.—and its theme is “The Numbers Don’t Lie:...

Silk-Protein Film

LifeGuide Blocking the First Step A silk-protein film aims to become an HIV prevention method by Chael Needle   When we think of HIV prevention in sexually active...

Matters of Survival

Is better HIV treatment related to improved survival after an individual is diagnosed with an AIDS-defining opportunistic illness (AIDS-OI)? That was one of the...

Heart Break in Melbourne

LifeGuide Heart Break in Melbourne Cardiovascular disease studies focus on assessment, management & treatment by Jeannie Wraight Cardiovascular disease (CVD) has become a leading cause of illness and...

Fast-Tracked or Foiled?

Last month, the Member States of the United Nations adopted the “Political Declaration on HIV and AIDS: On the Fast-Track to Accelerate the Fight...

The Road Ahead

LifeGuide Treatment Horizons The Road Ahead New candidates hold promise for ARV therapy & therapeutic vaccines by Mariel Selbovitz, MPH The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...

Developing Doravirine

LifeGuide Running Into Options An NNRTI candidate seeks to keep on track to expand therapies by Chael Needle In this next-generation era of anti-HIV meds, research and development...

Responding to TB

LifeGuide Rapid Response Why advances in point-of-care TB diagnostics determine the future of the AIDS crisis by Mariel Selbovitz, MPH TB—one of the greatest killers and what appears...